Semaglutide and liraglutide, two leading GLP-1 drugs, demonstrated significant weight reduction in clinical trials, with semaglutide achieving up to 15% body weight loss over 68 weeks
for example, weekly injections may continue to have an effect for 12 weeks after cessation, while daily injections stop having an effect within 2448 h after stopping [22]
If left untreated, it can lead to Heart palpitations and shortness of breath Weakness, tiredness, or lightheadedness Pale skin Vision loss Constipation, diarrhea, loss of appetite, or gas A smooth tongue Depression Memory loss Behavioral changes Numbness or tingling Muscle weakness Problems walking not trying to give you the wobbles here!), low levels of B12 can be linked to the development of pernicious anemia, dementia, or osteoporosis
2 As with most of the beneficial effects of GLP-1 in type-2 diabetic patients, the exact mechanism by which it induces satiety is not known and more research is underway
Sleep and memory consolidation dysfunction in psychiatric disorders: evidence for the involvement of extracellular matrix molecules
However, experimental designs in rodent models may not be transferrable to human situations